P53 activation inhibits all types of hematopoietic progenitors and all stages of megakaryopoiesis

TP53 also known as p53 is a tumor suppressor gene mutated in a variety of cancers. P53 is involved in cell cycle, apoptosis and DNA repair mechanisms and is thus tightly controlled by many regulators. Recently, strategies to treat cancer have focused on the development of MDM2 antagonists to induce...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahfoudhi, Emna, Lordier, Larissa, Marty, Caroline, Pan, Jiajia, Roy, Anita, Roy, Lydia, Rameau, Philippe, Abbes, Salem, Debili, Najet, Raslova, Hana, Chang, Yunhua, Debussche, Laurent, Vainchenker, William, Plo, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5077990/
https://www.ncbi.nlm.nih.gov/pubmed/26959882
http://dx.doi.org/10.18632/oncotarget.7881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5077990/
https://www.ncbi.nlm.nih.gov/pubmed/26959882
http://dx.doi.org/10.18632/oncotarget.7881

Ejemplares similares